Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuronetics (STIM) EBIT Margin (2017 - 2025)

Neuronetics (STIM) has disclosed EBIT Margin for 9 consecutive years, with 19.63% as the latest value for Q3 2025.

  • On a quarterly basis, EBIT Margin rose 2208.0% to 19.63% in Q3 2025 year-over-year; TTM through Sep 2025 was 29.16%, a 869.0% increase, with the full-year FY2024 number at 46.15%, down 333.0% from a year prior.
  • EBIT Margin was 19.63% for Q3 2025 at Neuronetics, up from 21.15% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 19.63% in Q3 2025 to a low of 71.47% in Q1 2022.
  • A 5-year average of 45.03% and a median of 45.99% in 2021 define the central range for EBIT Margin.
  • Biggest YoY gain for EBIT Margin was 3410bps in 2021; the steepest drop was -3257bps in 2021.
  • Neuronetics' EBIT Margin stood at 45.99% in 2021, then rose by 8bps to 42.46% in 2022, then surged by 49bps to 21.79% in 2023, then plummeted by -134bps to 51.0% in 2024, then soared by 62bps to 19.63% in 2025.
  • Per Business Quant, the three most recent readings for STIM's EBIT Margin are 19.63% (Q3 2025), 21.15% (Q2 2025), and 34.45% (Q1 2025).